Afuco™ Anti-CA9 ADCC Recombinant Antibody, ADCC Enhanced (AFC-TAB-H43)

CAT#: AFC-TAB-H43

This product is an ADCC enhanced antibody produced by our Afuco™ platform. Recombinant Chimeric antibody to Human CA9.

Gene Expression
Figure 1 Immunofluorescent staining of human cell line A-431 Figure 2 Stomach Figure 3 RNA cell line category: Group enriched (A-431, HDLM-2, hTERT-RPE1, U-87 MG)

Specifications

  • Host Species
  • Chimeric
  • Derivation
  • Chimeric
  • Type
  • ADCC enhanced antibody
  • Specificity
  • CA9 (carbonic anhydrase IX, CAIX, MN, G250) [Homo sapiens]
  • Species Reactivity
  • Human
  • Applications
  • ELISA, FC, IP, FuncS, IF, Neut
  • Conjugate
  • Unconjugated
  • Trade name
  • Redectane
  • Generic Name
  • Girentuximab
  • Related Disease
  • Kidney tumours

Product Property

  • Purity
  • >95% by SDS-PAGE
  • Storage
  • Store at +4°C short term (1-2 weeks). Aliquot and store at -20°C long term. Avoid repeated freeze/thaw cycles.

Target

  • Alternative Names
  • CA9; carbonic anhydrase IX; carbonic anhydrase 9; CAIX; carbonic dehydratase; MN; RCC associated protein G250; pMW1; CA-IX; P54/58N; membrane antigen MN; carbonate dehydratase IX; RCC-associated antigen G250;
REVIEWS AND Q&AS CITATIONS RESOURCES DOWNLOADS RELATED PRODUCTS
Inquiry
Navs

Customer Review

Submit a review or a question

There are currently no Customer reviews or questions for AFC-TAB-H43. Click the button above to contact us or submit your feedback about this product.

Submit Your Publication

Published with our product? Submit your paper and receive a 10% discount on your next order! Share your research to earn exclusive rewards.

Article title:
DOI/PubMed URL:
Email:
Name:

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Biosimilar Overview

Please refer to Girentuximab Overview to learn more about the mechanism of action, clinical projects, and approved drugs of Girentuximab.

Downloadable Resources

Download resources about recombinant antibody development and antibody engineering to boost your research.

Product Notes

This is a product of Creative Biolabs' Hi-Affi™ recombinant antibody portfolio, which has several benefits including:

• Increased sensitivity
• Confirmed specificity
• High repeatability
• Excellent batch-to-batch consistency
• Sustainable supply
• Animal-free production

See more details about Hi-Affi™ recombinant antibody benefits.

Datasheet

MSDS

COA

Certificate of Analysis Lookup

To download a Certificate of Analysis, please enter a lot number in the search box below. Note: Certificate of Analysis not available for kit components.

Lot Number:

Protocol & Troubleshooting

We have outlined the assay protocols, covering reagents, solutions, procedures, and troubleshooting tips for common issues in order to better assist clients in conducting experiments with our products. View the full list of Protocol & Troubleshooting.

See other products for "Girentuximab"

Anti-CAIX/CA9 Recombinant Antibody (Girentuximab)
Recombinant chimeric antibody expressed in CHO binding to human CAIX. Girentuximab is a chimeric monoclonal antibody designed for the treatment of renal cell carcinoma.
DrugMonitor™ Anti-Girentuximab Antibody (VS-1224-YC521)
Girentuximab is a chimeric (mouse/human) monoclonal antibody targeting carbonic anhydrase IX, expressed in 95% of clear cell renal cell carcinomas (RCC). The DrugMonitor™ Anti-Girentuximab Antibody (VS-1224-YC521) is an anti-drug antibody (ADA) against Girentuximab. This drug-based antibody is raised in mice immunized with the Girentuximab. The anti-Girentuximab antibody may be used in ELISA, pharmacokinetics (PK), and pharmacodynamics (PD) analyses, or serves as a reference standard in ADA assays. It also is an excellent tool for therapeutic drug monitoring, allowing to evaluate the drug efficacy and determine the drug concentration of the Girentuximab in samples.

See other products for "CA9"

Select a product category from the dropdown menu below to view related products.

CAT Product Name Application Type
TAB-707 Anti-CAIX/CA9 Recombinant Antibody (Girentuximab) WB, FuncS, IF, Neut, ELISA, FC, IP IgG1 - kappa
TAB-H43 Anti-Human CA9 Recombinant Antibody (TAB-H43) ELISA, IP, IF, Inhib IgG1 - kappa
CAT Product Name Application Type
MOR-0427 Hi-Affi™ Rabbit Anti-CA9 Recombinant Antibody (clone DS427AB) IHC-P, WB Rabbit IgG
CAT Product Name Application Type
HPAB-0782-CN Human Anti-CA9 Recombinant Antibody (clone G119) FC, ELISA, Inhib, Cyt, Bioimaging Human IgG
HPAB-0784-CN Human Anti-CA9 Recombinant Antibody (clone G37) FC, ELISA, Inhib, FuncS, Cyt, Bioimaging, IHC Human IgG
VS3-QX140 Mouse Anti-CA9 Recombinant Antibody (clone 5B5-B10-A2) WB, IHC, ICC, FC, ELISA Mouse IgG1
VS7-HM283 Mouse Anti-CA9 Recombinant Antibody (clone 2D3) WB, IHC, FCM Mouse IgG1
VS7-HM284 Mouse Anti-CA9 Recombinant Antibody (clone CBL090HM) WB, IHC-p, IF, FCM, ELISA Mouse IgG
CAT Product Name Application Type
VS-0424-XY37 AbPlus™ Anti-CA9 Magnetic Beads (12F10) IP, Protein Purification
VS-0724-YC1029 AbPlus™ Anti-CA9 Magnetic Beads (VS-0724-YC1029) IP, Protein Purification
CAT Product Name Application Type
VS-0325-FY54 Human Anti-CA9 (clone G37) scFv-Fc Chimera FC, ELISA, Inhib Human IgG1, scFv-Fc
CAT Product Name Application Type
VS-0425-YC94 Recombinant Anti-CA9 Vesicular Antibody, EV Displayed (VS-0425-YC94) ELISA, FC, Neut, Cell-uptake
Specific Inquiry
Go to compare Add to compare

For research use only. Not intended for any clinical use. No products from Creative Biolabs may be resold, modified for resale or used to manufacture commercial products without prior written approval from Creative Biolabs.

Send Inquiry

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Go to compare

Go to compare